Moreno-Martínez FL, González CR, Lagomasino HÁL, Ibargollín HRS, Aladro MIF, Vega FLF, Mirabal RR, Bermúdez YGJ, Medrano PY, Bermúdez YR

Idioma: Español
Referencias bibliográficas: 17
Paginas: 67-72
Archivo PDF: 512.31 Kb.

RESUMEN

La estenosis del tronco coronario izquierdo se encuentra entre el 3-5 % de los pacientes a los que se les realiza una coronariografía, pero su oclusión total es rara (0,05-0,1 %). En este artículo presentamos el caso de un paciente de 42 años con oclusión total de este vaso, que presentaba además, una estenosis de 85 % en la arteria coronaria derecha y fue revascularizado quirúrgicamente de forma exitosa. Se implantaron 3 injertos, mamaria a la descendente anterior, y vena safena a una obtusa marginal y a la descendente posterior. Se presentan las imágenes angiográficas y de la cirugía, y se comentan las alternativas terapéuticas, donde lo más importante es individualizar el tratamiento, con el objetivo de brindar la mejor opción a cada paciente en particular. Para lograrlo es imprescindible una excelente relación del equipo de trabajo donde, como en este caso, el cardiólogo intervencionista y el cirujano cardiovascular se complementen, para el bien del paciente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Trehan V, Mehta V, Mukhopadhyay S, Yusuf J, Arora R. Percutaneous stenting of chronic total occlusion of unprotected left main coronary artery. Indian Heart J. 2003;55:172-4.

2. Zimmern SH, Rogers WJ, Bream PR, Chaitman BR, Bourassa MG, Davis KA, et al: Total occlusion of the left main coronary artery: the Coronary Artery Surgery Study (CASS) experience. Am J Cardiol. 1982;49:2003-10.

3. Li JJ, Xu B, Chen JL. Stenting for left main coronary artery occlusion in adolescent: A case report. World J Cardiol. 2010;2(7):211-4.

4. Herrick J. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;59:2015-20.

5. Kandzari DE, Ormiston JA. Revascularization for unprotected left main coronary artery disease: An evolution in clinical decision making. Curr Cardiol Rep. 2011;13:424-31.

6. Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center- Left MAIN Revascularization) registry. J Am Coll Cardiol. 2010;56(17):1366–75.

7. Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv. 2010;3(6):612-23.

8. Nassar H, Y Rozenman, Gotsman MS. Total occlusion of the left main coronary artery and normal left ventricular function despite critical narrowing of the right coronary artery. Eur Heart J. 1992;13:850-2.

9. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial. Circulation 2010;121: 2645-53.

10. Naik H, White AJ, Chakravarty T, Forrester J, Fontana G, Kar S, et al. A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv. 2009; 2(8):739-47.

11. Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, et al. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. J Am Coll Cardiol. 2009;54(17):1576-88.

12. Kushner FG, Hand M, Smith SC, King SB 3rd, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(22):2271-306.

13. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010;31(20):2501-55.

14. Sheiban I, Sillano D, Biondi-Zoccai G, Chieffo A, Colombo A, Vecchio S, et al. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol. 2009;54(13):1131–6.

15. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574-651.

16. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multi-center registry. Circulation. 2007;116(2):158–62.

17. Tamburino C, Capranzano P, Capodanno D, Tagliareni F, Biondi-Zoccai G, Sanfilippo A, et al. Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation. JACC Cardiovasc Interv. 2010;3(6): 624-31.